KIT (c-KIT) Mutation Analysis | NeoGenomics Laboratories

Code

MOG-KITX-01CZ

Test

Active-Compendium

81272

Clinical

Oncology,Pathology

Peripheral blood: 5 mL in EDTA tube.
Bone marrow: 2 mL in EDTA tube.
FFPE solid tumor tissue: Paraffin block is preferred. Alternatively, send 1 H&E slide plus 5-10 unstained slides cut at 5 or more microns. Please use positively-charged slides and 10% NBF fixative. Do not use zinc fixatives.
Note: Test is DNA-based. Please select Extract & Hold - DNA if specimen hold service is desired.

Mon, 01/13/2025 - 12:00

Wed, 01/22/2025 - 12:00

Molecular

Global

Flag Active

True

Orderable Test Description

Bi-directional sequencing of KIT exons 8, 9, 11, 13 and 17 for detection of activating mutations including the common mutation D816V. For solid tumors, tumor enrichment is performed before extraction. In hematological disease, testing may be performed on plasma to increase sensitivity. Testing is approved for specimens from the state of New York.

Orderable Turn Around Time

7 Days

Keywords

Meta Description

Bi-directional sequencing of KIT exons 8, 9, 11, 13 and 17 for detection of activating mutations including the common mutation D816V. For solid tumors, tumor enrichment is performed before extraction. In hematological disease, testing may be performed on plasma to increase sensitivity.

Orderable Biomarkers

KIT

NY Approved

True

Orderable Biomarkers JSON

{"DNA Sequencing": {"SNVs + Indels": ["KIT"]}}

Keywords string

kit, c kit, c-kit, kit mutation KIT (c-KIT) Mutation Analysis

Title URL

kit-c-kit-mutation-analysis